RPS6KB1 and small cell lung carcinoma: Similarly, the levels of phosphorylated RPS6KB1/p70S6K were elevated in the small cell lung cancer cells that acquired resistance to cisplatin, and activation of RPS6KB1/p70S6K contributes to cisplatin resistance (Supplementary Table S1).